The balance between cure and late effects in childhood Hodgkin's lymphoma: The experience of the German-Austrian Study-Group since 1978. An ovewiew

Annals of Oncology

Volumn 7, Issue SUPPL. 4, 1996, Pages

  Schellong, G ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Gonadal dysfunction after chemotherapy; Late effects of chemotherapy; OEPA; OPA; OPPA; Treatment of Hodgkin's disease in children

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PROCARBAZINE;

ADOLESCENT; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT PLANNING;

EID: 0029796647     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/7.suppl_4.S67     Document Type: Conference Paper

References (23)

1. Blayney DW, Longo DL, Young RC et al. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 1987; 316: 710-4.
2. Bonnadonna G, Santoro A. ABVD chemotherapy in the treatment of Hodgkin's disease. Cancer Treat Rev 1982; 9: 21-35.
3. Breu H, Schellong G, Grosch-Wörner A et al. Wannenmacher: Abgestufte Chemotherapie und reduzierte Strahlendosis beim Morbus Hodgkin im Kindesalter - ein Bericht über 170 Patienten der kooperativen Therapiestudie HD 78. Klin Pädiat 1982;194:233-41.
4. Brämswig JH, Heiermann E, Heimes U et al. Ovarian function in 63 girls treated for Hodgkin's disease (HD) according to the West-German DAL-HD-78 and DAL-HD-82 therapy study. Med Pediat Oncol 1989;17:344 (Abstr).
5. Brämswig JH, Heimes U, Heiermann E et al. The effect of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's Disease during childhood or adolescence. Cancer 1990;65:1298-302.
6. Brämswig JH, Hörnig-Franz I, Riepenhausen M, Schellong G. The challenge of pediatric Hodgkin's Disease - where is the balance between cure and long-term toxicity? A report of the West German multicenter studies DAL-HD-78, DAL-HD-82, and DAL-HD-85. Leuk Lymph 1990;2:183-93.
7. Brämswig JH, Schellong G, Schlegel W et al. Testicular function in boys after treatment for Hodgkin's disease with or without procarbazine. Exp Clin Endocrinol 1993; 101 (Suppl): 98 (Abstr).
8. Chapman RM, Sutcliffe SB, Malpas JS. Male gonadal dysfunction in Hodgkin's disease: A prospective study. J Am Med Assoc 1981;245:1323-8.
9. De Vita VT, Serpick A, Carbone PP. Combination chemotherapy in the treatment of advanced HD. Ann Int Med 1970; 73: 881-95.
10. Donaldson SS, Kaplan HS. Complications of treatment of Hodgkin's disease in children. Cancer Treatm Rep 1982; 66: 977-89.
11. Donaldson SS, Link MP. Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol 1987;5:742-9.
12. Green DM, Gingell RL, Pearce J et al. The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. J Clin Oncol 1987;5:239-45.
13. Grulich M, Schöntube M, Dörffel W. Bestrahlungsfolgen bei Kindern mit Lymphogranulomatose. Pädiatr Grenzgeb 1990; 29:115-7.
14. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993;11:1208-15.
15. Hassel JU, Brämswig JH, Schlegel W, Schellong G. Testikuläre Funktion nach OPA/COMP-Chemotherapie ohne Procarbazin bei Jungen and Mädchen mit Morbus Hodgkin. Klin Pädiat 1991;203:268-72.
16. Henry-Amar B, Pellae-Cosset B, Bayle-Weisgerber C et al. Risk of secondary acute leukemia and preleukemia after Hodgkin's disease: The Institute Gustave-Roussy experience. Rec Results Cancer Res 1989;117:270-83.
17. Hudson MM, Greenwald C, Thompson E et al. Efficacy and toxicity of multiagent treatment with chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 1993;11:100-8.
18. Hunger SP, Link MP, Donaldson SS. Long-term results of ABVD/MOPP and low-dose involved field radiotherapy in pediatric Hodgkin's disease: The Stanford experience. Proc Am Soc Clin Oncol 1993;384.
19. Joenssu H. Myocardial infarction after irradiation in Hodgkin's disease. A review. Rec. Results Cancer Res 1993;130:157-63.
20. Kaplan HS. Hodgkin's Disease. Second Ed. Cambridge: Harvard University Press 1980.
21. Meadows AT, Obringer AC, Lansberg P et al. Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Med Pediat Oncol 1989; 17:477-84.
22. Meffered JM, Donaldson SS, Link MP. Pediatric Hodgkin's disease. Pulmonary, cardiac and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys 1989;16:679-85.
23. Oberlin O, Leverger G, Pacquement H et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: The experience of the French Society of Pediatric Oncology. J Clin Oncol 1992;10:1602-8.